User profiles for G. Trifirò

Gianluca Trifirò

- Verified email at unime.it - Cited by 11962

giuseppe trifiro

- Verified email at icsmaugeri.it - Cited by 3670

Clinical and economic burden of adverse drug reactions

J Sultana, P Cutroneo, G Trifirò - Journal of Pharmacology …, 2013 - journals.sagepub.com
Adverse drug reactions (ADRs) are unwanted drug effects that have considerable economic
as well as clinical costs as they often lead to hospital admission, prolongation of hospital …

Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

…, A Fontana, F Salvo, S Messina, G Trifirò - Orphanet journal of rare …, 2020 - Springer
Background Duchenne Muscular Dystrophy (DMD) is a rare disorder caused by mutations
in the dystrophin gene. A recent systematic review and meta-analysis of global DMD …

COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current …

…, C Reno, M Tuccori, A Vannacci, G Zanoni, G Trifirò - Drug safety, 2021 - Springer
To date, four vaccines have been authorised for emergency use and under conditional
approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 …

Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project

PM Coloma, MJ Schuemie, G Trifiro… - … and drug safety, 2011 - Wiley Online Library
Purpose In this proof‐of‐concept paper we describe the framework, process, and preliminary
results of combining data from European electronic healthcare record (EHR) databases for …

Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study

G Trifirò, P Morabito, L Cavagna, C Ferrajolo… - Annals of the …, 2013 - ard.bmj.com
… Gianluca Trifirò1,2, … Correspondence to Gianluca Trifirò, Department of Clinical and
Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, …

[HTML][HTML] Safety of sentinel node biopsy in pregnant patients with breast cancer

O Gentilini, M Cremonesi, G Trifiro, M Ferrari, SM Baio… - Annals of oncology, 2004 - Elsevier
Background Lymphoscintigraphy (LS) and sentinel lymph node biopsy (SLNB) have typically
been contraindicated for pregnant patients diagnosed with breast cancer because they are …

Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines

…, S Crisafulli, G Puglisi, G Caramori, G Trifirò - Drug safety, 2020 - Springer
The global COVID-19 pandemic has led to a race to find medications that can improve the
prognosis of the disease. Azithromycin, in association with hydroxychloroquine or chloroquine…

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care

…, MCJM Sturkenboom, A Filippi, G Trifiro… - Journal of …, 2005 - journals.lww.com
… 11 Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G. Secondary prevention of
stroke in Italy: a cross-sectional survey in family practice. Stroke 2003; 34:1010–1014. … 15 …

Policies for biosimilar uptake in Europe: an overview

…, GW Selke, S Spillane, L McCullagh, G Trifirò… - PloS one, 2017 - journals.plos.org
Background Across European countries, differences exist in biosimilar policies, leading to
variations in uptake of biosimilars and divergences in savings all over Europe. Objectives The …

Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma

…, SJ Stoeckli, JB Thomsen, G Trifiro… - European journal of …, 2009 - Springer
Involvement of the cervical lymph nodes is the most important prognostic factor for patients
with oral/oropharyngeal squamous cell carcinoma (OSCC), and the decision whether to …